Dopaminergic, serotonergic, and cholinergic pathways affect GNS survival
GBM tumors and patient-derived GNS express functional DRD4 receptor
DRD4 antagonism selectively targets GNS growth in vitro and in vivo
GNS are vulnerable to DRD4-mediated disruption of autophagy-lysosomal pathway